Lamisil DermGel

Lamisil DermGel Adverse Reactions

terbinafine

Manufacturer:

GlaxoSmithKline Consumer

Distributor:

DKSH
Full Prescribing Info
Adverse Reactions
Adverse reactions are listed below by system organ class and frequency. Frequencies are defined as: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to 1/1,000); very rare (<1/10,000), or not known (cannot be estimated from available data). Adverse reactions indentified during post-marketing use are reported voluntarily from a population of uncertain size, the frequency of these reactions is not known but likely to be rare or very rare. Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness. (See table.)

Click on icon to see table/diagram/image
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in